Adaptive Biotechnologies President and COO Julie Rubinstein reports sale of $998,097.44 in common shares
ADPT•Julie Rubinstein sold 35,643 Adaptive Biotechnologies common shares from Oct. 27 to 29, 2026, in a sale valued at $998,097.44. She exercised options for the same number of shares at $12.14 each.
1. Share transactions
A Form 4 showed that Adaptive Biotechnologies President and COO Julie Rubinstein sold 35,643 common shares from Oct. 27 to 29, 2026, and exercised options for the same number of shares at $12.14 each. After the transactions, her direct holdings remained at 377,802 common shares, and she had 130,276 stock options remaining.
